Onartuzumab

DB11746InvestigationalProtein Based Therapies

Onartuzumab has been used in trials studying the treatment of Neoplasms, Lung Cancer, Glioblastoma, Gastric Cancer, and Colorectal Cancer, among others.

Mechanism: Pharmacologically active on Hepatocyte growth factor receptor
Curator reviewed
Code names: PRO143966 · RO5490258

Resolves to

Compound

UNIIMS1J9720WCCAS1133766-06-9

Targets

P08581MET

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

13Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Onartuzumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account